Cite
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID- 19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
MLA
Rose, Angela M. C., et al. “Vaccine Effectiveness against COVID-19 Hospitalisation in Adults (≥ 20 Years) during Omicron-Dominant Circulation: I-MOVE-COVID- 19 and VEBIS SARI VE Networks, Europe, 2021 to 2022.” Eurosurveillance (15607917), vol. 28, no. 47, Nov. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.2807/1560-7917.es.2023.28.47.2300186.
APA
Rose, A. M. C., Nicolay, N., Martín, V. S., Mazagatos, C., Petrović, G., Baruch, J., Denayer, S., Seyler, L., Domegan, L., Launay, O., Machado, A., Burgui, C., Vaikutyte, R., Niessen, F. A., Loghin, I. I., Husa, P., Aouali, N., Panagiotakopoulos, G., Tolksdorf, K., & Horváth, J. K. (2023). Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID- 19 and VEBIS SARI VE networks, Europe, 2021 to 2022. Eurosurveillance (15607917), 28(47), 1–17. https://doi.org/10.2807/1560-7917.es.2023.28.47.2300186
Chicago
Rose, Angela M. C., Nathalie Nicolay, Virginia Sandonis Martín, Clara Mazagatos, Goranka Petrović, Joaquin Baruch, Sarah Denayer, et al. 2023. “Vaccine Effectiveness against COVID-19 Hospitalisation in Adults (≥ 20 Years) during Omicron-Dominant Circulation: I-MOVE-COVID- 19 and VEBIS SARI VE Networks, Europe, 2021 to 2022.” Eurosurveillance (15607917) 28 (47): 1–17. doi:10.2807/1560-7917.es.2023.28.47.2300186.